Catalyst Wire Dossier Catalyst Wire Dossier

Isosorbide-5-Mononitrate Extended-Release Tablets

Isosorbide-5-Mononitrate · Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Isosorbide-5-Mononitrate Extended-Release Tablets, covering 2018-06-15 to 2018-06-15. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects [Phase 1]

See pricing